Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Masked hypertension refers to a condition with normal office and elevated home or ambulatory BP without antihypertensive medication. It is a common phenomenon in a general population with a prevalence of 8-17%. However, the persistence of masked hypertension is limited, and agreement between home and ambulatory BP is only moderate.
Different definitions for masked hypertension are still used, for example, elevated 24-hour, daytime, working or nighttime BP. Masked hypertension has been associated with high-normal office BP, obesity, male gender, and metabolic or lifestyle risk factors but these findings have not always been consistent. Masked hypertension has also been related to target organ damage, most commonly left ventricular hypertrophy.
The cardiovascular risk associated with masked hypertension in a general population is still controversial and may, in part, be related to other concomitant cardiovascular risk factors. There is no evidence on the treatment and cost-effectiveness of masked hypertension. Implementation of out-of-office BP measurement and identification of masked hypertension in clinical practice requires interaction with general practitioners.
Explore more at: https://www.omicsgroup.org/journals/editorialboard-hypertension-open-access.php